Quantitative cerebral water content mapping in hepatic encephalopathy.
about
Magnetic resonance imaging and spectroscopy in hepatic encephalopathyEncephalopathy and liver transplantation.Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy.Fast and high-resolution quantitative mapping of tissue water content with full brain coverage for clinically-driven studies.Magnetic resonance of the brain in chronic and acute liver failure.Analysis of proton-density bias corrections based on T1 measurement for robust quantification of water content in the brain at 3 Tesla.Increased cerebral water content in hemodialysis patientsHepatic encephalopathy in acute-on-chronic liver failure.Imaging of sodium in the brain: a brief review.Covert hepatic encephalopathy: elevated total glutathione and absence of brain water content changes.Quantitative T1 and proton density mapping with direct calculation of radiofrequency coil transmit and receive profiles from two-point variable flip angle data.Brain edema: a valid endpoint for measuring hepatic encephalopathy?Magnetic resonance T2-relaxometry and 2D L-correlated spectroscopy in patients with minimal hepatic encephalopathy.Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining.Hepatobiliary Quiz (Answers)-14 (2015).Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathyEffect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.Pathogenesis and diagnosis of hepatic encephalopathy.A new algebraic method for quantitative proton density mapping using multi-channel coil data.Therapeutic effects of methionine sulfoximine in multiple diseases include and extend beyond inhibition of glutamine synthetase.Qualifying and quantifying minimal hepatic encephalopathy.(1)H and (31)P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism.Hepatic encephalopathy associated with cancer or anticancer therapy.Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy.Ephrin/Ephrin receptor expression in ammonia-treated rat astrocytes and in human cerebral cortex in hepatic encephalopathy.Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats.Neuropathological changes in the brain of pigs with acute liver failure.Gene expression profiling in the cerebral cortex of patients with cirrhosis with and without hepatic encephalopathy.Correction of systematic errors in quantitative proton density mapping.Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation.MR parameter quantification with magnetization-prepared double echo steady-state (MP-DESS).Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes.Hepatic Encephalopathy and Astrocyte Senescence
P2860
Q27025246-54D38D87-1CCB-42B3-9581-64AF4CDD7563Q30577611-4CF47958-7C72-421B-9E2C-38755D488C96Q30578055-4C7E8644-D5A8-4202-8F00-9C788E569F0CQ30667839-D24374FD-D1CD-4DCB-BE7B-F3529C1C0300Q30697969-6E293953-C14F-4E92-94FD-5A1F6282E7B6Q30736016-CEC6CCA3-F3D9-4A4C-B60F-2F589D15D79CQ30920004-09C2FC2B-2E05-44BC-9961-90C6244DF8A7Q30959584-124478F5-97A7-495C-9E1A-4819509A7D96Q31003866-6B9B3F82-0C77-48FB-91DA-43C772C23CDDQ31022430-6688377B-0140-4B15-90AE-6CFAB7EF79B3Q31036411-D0DD8F5F-F57B-4CEE-9083-43D4BB836F16Q31106217-BC467ED8-CC91-4F16-BBB2-5937BADA6145Q33512564-D8D6D17D-278C-455C-AB4F-EE76A0148DD1Q35513402-E4D967D3-78E4-4E99-9098-144D28B287D7Q35818316-895210AE-2430-4A26-B704-3FB6D8D9C94EQ36091445-9CFEB59D-92EF-4B47-8B70-CAD6700668C0Q37627757-E970539C-108F-4251-91C5-158387584666Q37763086-8984FA6D-5406-40FF-80F6-D7DD5B22D9BDQ38698615-8AC870E7-3766-4D0E-80D1-C7C8FCA6079DQ39177919-61CC2326-5187-4591-84D6-C47E6001A826Q40494136-D6005E36-BCE5-49A9-9713-BAAEFBBC1C58Q40647592-CE2994ED-C6C3-45F6-9CED-578DE5899909Q41111818-F2131E30-0C46-4CE2-86BA-9DE5C9283C26Q42203162-669B33D7-1391-4E4B-8751-1B7CB82D5219Q42204413-EE53AFED-99B6-4019-BC94-EA893689BC52Q43521848-33981C9B-2434-4DEB-A9D1-F441FE64832AQ45329044-09425EAB-AF47-4FC6-8309-7F6F4FDAB387Q48207013-07C2A7E8-71BA-4278-A7AF-201D1CB90622Q48797952-88C96580-143A-4E72-A89C-B2349864E629Q49132753-18A07FAB-EB31-4E34-A8C6-EEE2F20D44A4Q51178617-1271515A-1785-4A18-BE3C-C30251746BBBQ52149537-D9AA4283-F4F2-4562-AC49-CE2DCB28CCFBQ57300673-E357095B-B511-4BF0-8DA6-092E469A3131
P2860
Quantitative cerebral water content mapping in hepatic encephalopathy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Quantitative cerebral water content mapping in hepatic encephalopathy.
@ast
Quantitative cerebral water content mapping in hepatic encephalopathy.
@en
type
label
Quantitative cerebral water content mapping in hepatic encephalopathy.
@ast
Quantitative cerebral water content mapping in hepatic encephalopathy.
@en
prefLabel
Quantitative cerebral water content mapping in hepatic encephalopathy.
@ast
Quantitative cerebral water content mapping in hepatic encephalopathy.
@en
P2093
P50
P1433
P1476
Quantitative cerebral water content mapping in hepatic encephalopathy
@en
P2093
P304
P356
10.1016/J.NEUROIMAGE.2008.02.057
P407
P577
2008-03-08T00:00:00Z